Ummid Assistant

IDB scholarship forms available at Bhopal's Companion School

IGNOU's preparatory course for students desiring higher education

Welcome Guest! You are here: Home » Health

Why don't you reduce cancer drug price, SC asks Novartis

Tuesday September 11, 2012 10:31:29 PM, IANS

Related Article

US pushing India to hike cancer drug price

Obama administration's multiple "strategies to affect drug pricing abroad by using American international political muscle", according to a Huffington Post investigative report, became apparent in a testimony by US Patent and Trademark Office  »

New Delhi: Pharma major Novartis AG Tuesday said it was the author of beta crystalline, a form of a compound used in an anti-cancer drug, while the Supreme Court asked the company why it could not reduce its medicine's price.

"Why don't you reduce the price ... that will be a better and stronger way of establishing your bonafides of helping the poor," the court said, adding: "Rs.1.2 lakh per month is too high to afford a treatment."

The company was asserting its claim for getting a patent for the compound form in India and its exclusive marketing rights.

An apex court bench of the Justice Aftab Alam and Justice Ranjana Prakash Desai was told that Novartis AG developed the beta crystalline form of imatinib mesylate, which is used for the treatment of the chronic mycloid leukemia.

Senior counsel Gopal Subramanium, who appeared for the Novartis, told the court that imatinib mesylate was known as a compound but its efficacy as an anti-cancer drug was not known and was discovered by the company in its beta crystalline form.

The company said the cancer treatment medicine was intended to kept within the reach of the poor patients and a large number of poor patients were being provided with the cancer treating medicine free of cost.

As Justice Alam said: "You have no legal obligation (of proving free medicine)", Subramanium replied: "I have commitment and responsibility." However, counsel said that he would take instructions on the query by the court.

Justice Alam asked Novartis: "I am surprised that you can reduce the price and knock out your competitors" and yet you were not adopting that course.

"There are some constraints when it comes to pricing," Subramanium said adding that Novartis was a corporate entity with stake holders.

Novartis challenged in the apex court the Intellectual Property Appellate Board's (IPAB) decision which held that beta crystalline form of imatinib mesylate was an invention but did not agree to grant patent for it.

Subramanium told the court that its medicine which was being marketed by the trade name of "Gleevec" had been patented in 35 countries including by the US.

As Justice Alam observed "this is a difficult country", Novartis's counsel Subramanium said: "I don't think so".

Subramanium told the court that Novartis was not fighting legal battle for the sake of money but as a matter of honour. "The purpose of this case is not for money but the vindication of honour."

The court was told that a large number of poor patients were being provided with the cancer treating medicine free of cost.

The court asked Subramanium what was the guarantee that if Novartis' prayer was allowed then it would continue with its scheme of providing free cancer treatment medicine to deserving patients.

"It is not intended to be kept out of reach of the poor," Subramanium said.




 

 
 


 


 



 

Home | Top of the Page

Comments

Note: By posting your comments here you agree to the terms and conditions of www.ummid.com

Comments powered by DISQUS

i

i

 

More Headlines

Will Manmohan Singh go to Pakistan this year?

Cambridge loses No.1 spot to MIT

Cartoonist Trivedi gets bail, refuses freedom till charge dropped

US marks 9/11 sans politicians at ground zero

William Dalrymple sad over Hyderabad shedding its past

Narendra Modi kickstarts poll campaign in Gujarat

India posts 25 percent increase in visas on arrival

Blue chip British companies at Kerala investor's meet

HP plans to cut 2,000 more jobs

No guidelines to regulate media reporting of sub-judice matters: SC

Murray first Brit to win Grand Slam men's singles title in 76 years

Gujarat victims great fight back

 

Top Stories

Arafat was poisoned, believed from day one: Foundation

The Yasser Arafat Foundation on Sunday there was “no need” for more proof the Palestinian leader was poisoned in what appeared to be a stance against French plans to exhume his body.  »

France opens murder investigation in Arafat’s death: Sources

Arafat's widow calls to exhume the dead leader's body

 

  Most Read

William Dalrymple sad over Hyderabad shedding its past

Historian and writer William Dalrymple is sad that Hyderabad has shed much of its past and called for a major effort for conservation and to popularize the history and culture of Deccan, nationally and  »

US marks 9/11 sans politicians at ground zero

Eleven years after terrorist attacks destroyed New York World Trade Center's twin towers, thousands gathered Tuesday at ground zero and elsewhere to mark the traumatic event in sombre ceremonies sans politicians. In the midst of a heated election campaign, both President Barack Obama  »

 

  News Pick

'Congress richest party, BJP next'

The Congress is the richest political party in India, followed by rival Bharatiya Janata Party (BJP), reveals data collected by think-tanks Association for Democratic Reforms and National Election Watch.  »

Palestinians ask Israel to amend economic agreement

The Palestinian National Authority (PNA) has officially asked Israel Sunday to amend a 1994 agreement regulating economic relations between the two sides. The request to review the Paris  »

'Peace accord with Palestinians more urgent for Israel than Iran attack'

A former head of Israeli military intelligence said Monday it would be dangerous to attack Iranian nuclear facilities without US backing in the near future. Amos Yadlin expressed his concerns at the International Institute for Counter-Terrorism World Summit, being held in Herzliya, near Tel Aviv,.  »

Partition adversely affected Muslims: Indian Vice President

Partition affected the Indian Muslims adversely, especially those in the country's northern and eastern regions, and its socio-economic impact remains understudied, said Vice President  »

 

Picture of the Day

Prime Minister Dr. Manmohan Singh and President of the Palestine National Authority Mahmoud Abbas at the delegation level talks, in New Delhi on September 11, 2012.

 

 
 
 
 
 
 
 
 

RSS  |  Contact us

 

| Quick links

News

 

Subscribe to

Ummid Assistant

 

National

Science & Technology

RSS

Scholarships

About us

International

Health

Twitter

Government Schemes

Feedback

Regional

History

Facebook

Education

Register

Politics

Opinion

Newsletter

Contact us

Business

Career

Education

     

 

 

Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange

Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.

© 2012 Awaz Multimedia & Publications. All rights reserved.